With a 27-fold higher expression in pancreatic cancer cells (compared with normal ductal cells) and an elevated serum level in 94% of the pancreatic cancer patients, LCN2 is reported as an early detection marker for pancreatic malignancies [248]. This evidence concerns the gene LCN2 and pancreatic neoplasm.